Clinical Trial 52327

Pearland, TX 77584


We are conducting this study to learn more about how effective, safe and tolerable a study drug called AZD9977 is when used in combination with dapagliflozin, in treating participants with heart failure and CKD.

At minimum: 

1)    Participant must be 21 years of age or older

2)    Documented diagnosis of stable symptomatic HF and and a medical history of typical symptoms and signs of HF in those who are currently receiving loop diuretic treatment

a.     Typical symptoms associated with HF: breathlessness, orthopnoea, paroxysmal nocturnal dyspnoea, reduced exercise tolerance, fatigue, tiredness, increased time to recover after exercise.

3) Left ventricular ejection fraction < 60% documented by the most recent echocardiogram 2D or 3D or cardiac magnetic resonance imaging within the last 12 months prior to screening.

Qualified Participants May Receive:

You will be reimbursed $90 per completed visit. You will also receive an additional $56.67 for travel. You will be paid following each completed visit.

If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.